JOHN HOPE FRANKLIN CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1838-01-01

Employees: 5K

Market Cap: -

Website: http://www.duke.edu

Clinical Trials

Secondary Prevention of Osteoporotic Fractures in Residents of Long-Term Care Facilities

Phase 2

Completed

Conditions: Hip Fractures
Osteoporosis

First Posted Date: 2006-01-24

Last Posted Date: 2023-10-26

Lead Sponsor: Duke University

Target Recruit Count: 64

Registration Number: NCT00280943

Locations: 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States

Computer Program in Improving Communication Between Doctors and Patients With Stage IV Cancer

Not Applicable

Completed

Conditions: Unspecified Adult Solid Tumor, Protocol Specific

Interventions: Behavioral: communication lecture
Behavioral: lecture plus CD-ROM

First Posted Date: 2006-01-13

Last Posted Date: 2014-02-06

Lead Sponsor: Duke University

Target Recruit Count: 800

Registration Number: NCT00276627

Locations: 🇺🇸
UPMC Cancer Center at UPMC Presbyterian, Pittsburgh, Pennsylvania, United States
🇺🇸
Duke Cancer Institute, Durham, North Carolina, United States

Zonisamide for Weight Reduction in Obese Adults

Not Applicable

Completed

Conditions: Obesity

Interventions: Drug: Zonisamide

First Posted Date: 2006-01-12

Last Posted Date: 2017-01-12

Lead Sponsor: Duke University

Target Recruit Count: 225

Registration Number: NCT00275834

Locations: 🇺🇸
Duke University Medical Centre, Durham, North Carolina, United States

Effects of Resistance and Aerobic Exercise on Cardiovascular Health

Phase 2

Completed

Conditions: Cardiovascular Diseases
Heart Diseases
Obesity
Hyperlipidemia
Insulin Resistance
Metabolic Syndrome X

Interventions: Behavioral: Resistance Training
Behavioral: Aerobic Exercise
Behavioral: Combo
Behavioral: Continued Sedentary lifestyle

First Posted Date: 2006-01-11

Last Posted Date: 2013-05-24

Lead Sponsor: Duke University

Target Recruit Count: 261

Registration Number: NCT00275145

Locations: 🇺🇸
Duke University, Durham, North Carolina, United States

Bevacizumab and Irinotecan in Treating Patients With Recurrent or Refractory Gliomas

Phase 2

Completed

Conditions: Brain and Central Nervous System Tumors

First Posted Date: 2005-12-22

Last Posted Date: 2014-07-21

Lead Sponsor: Duke University

Target Recruit Count: 68

Registration Number: NCT00268359

Locations: 🇺🇸
Duke Comprehensive Cancer Center, Durham, North Carolina, United States

Locomotor Experience Applied Post Stroke Trial

Phase 3

Completed

Conditions: Stroke

Interventions: Behavioral: Late locomotor training program
Behavioral: Home Exercise Program
Behavioral: Early locomotor training program

First Posted Date: 2005-10-25

Last Posted Date: 2014-07-16

Lead Sponsor: Duke University

Target Recruit Count: 408

Registration Number: NCT00243919

Locations: 🇺🇸
University of Southern California - PT Associates, Los Angeles, California, United States
🇺🇸
Centinela Freeman Memorial Hospital, Inglewood, California, United States
🇺🇸
Brooks Rehabilitation Hospital, Jacksonville, Florida, United States

and more 5 locations

3-D Transcranial Ultrasound Analysis Study

Not Applicable

Completed

Conditions: Cerebrovascular Accident
Intracranial Hypertension

First Posted Date: 2005-10-17

Last Posted Date: 2014-04-11

Lead Sponsor: Duke University

Target Recruit Count: 28

Registration Number: NCT00239525

Locations: 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States

Risk of Developing Antibodies to Heparin-PF4 After Heart Surgery

Completed

Conditions: Thrombosis

First Posted Date: 2005-10-12

Last Posted Date: 2013-02-25

Lead Sponsor: Duke University

Target Recruit Count: 1015

Registration Number: NCT00237328

Locations: 🇺🇸
Mayo Clinic, Rochester, Rochester, Minnesota, United States
🇺🇸
Duke University Medical Center, Durham, North Carolina, United States
🇺🇸
University of North Carolina, Chapel Hill, North Carolina, United States

and more 1 locations

Comparison of Oral Valganciclovir and Placebo for the Prevention of Cytomegalovirus (CMV) After Lung Transplantation

Phase 3

Completed

Conditions: Cytomegalovirus Infections

Interventions: Drug: valganciclovir
Other: Placebo

First Posted Date: 2005-09-28

Last Posted Date: 2024-10-04

Lead Sponsor: Duke University

Target Recruit Count: 136

Registration Number: NCT00227370

Locations: 🇺🇸
DukeUMC, Durham, North Carolina, United States

Testing Pharmacological Therapies for Pregnant Smokers

Phase 4

Terminated

Conditions: Pregnancy
Smoking

Interventions: Behavioral: Motivational interviewing for smoking cessation
Behavioral: Cognitive behaviors therapy
Drug: CBT + NRT

First Posted Date: 2005-09-23

Last Posted Date: 2014-07-21

Lead Sponsor: Duke University

Target Recruit Count: 181

Registration Number: NCT00224419

Locations: 🇺🇸
Womack Army Medical Center, Fayetteville, North Carolina, United States
🇺🇸
Duke University Medical Center, Durham, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy